Oracle's $664 Billion Backlog Meets a Founder Who Won't Sell

Oracle's Q1 FY2027 revenue rose 30% to $19.35B and backlog hit $664B, but free cash flow was negative $5.4B as capex reached $28.5B.

Larry Ellison's decision to cancel his 10b5-1 trading plan for Oracle shares — without disposing of a single stock and with no further sale intentions disclosed — landed quietly alongside the company's quarterly report last Thursday. It may prove the more telling disclosure of the two.

For a founder and executive chair to leave money on the table just as his company embarks on one of the heaviest capital spending programs in enterprise software history is a statement no analyst note can match. Ellison is publicly betting on his own strategy at the exact moment the market has begun to question it.

Record orders, muted applause

Oracle's fiscal 2027 first quarter delivered on the headline numbers. Revenue rose 30% to $19.35 billion, non-GAAP earnings per share came in at $1.92 — comfortably ahead of the $1.74 analysts had penciled in — and cloud infrastructure revenue surged 121% to $7.4 billion. Management guided second-quarter revenue growth of 30% to 34%, with the cloud unit expanding 64% to 71%, and lifted its full-year outlook to at least $90 billion in sales and $8.10 in adjusted EPS.

The backlog tells an even bigger story. Remaining performance obligations reached $664 billion, swollen by more than $30 billion in fresh AI cloud contracts signed during the quarter alone. Oracle also brought 850 megawatts of additional data center capacity online.

Investors were unmoved. The stock slipped 1.4% on the report and has lost 5.1% over the past seven trading sessions, closing Friday at €129.72 — roughly 55% below its 52-week high of €288.95, set last September. Year to date, the shares are down 22%.

The cash flow question

What separates Oracle's income statement from its cash position is the scale of the buildout. Operating cash flow hit a quarterly record of $23 billion, but capital expenditures of $28.5 billion left free cash flow at negative $5.4 billion. That was still far better than the negative $9.56 billion analysts had feared — a relief for shareholders who had grown anxious about the burn rate.

The restructuring ledger adds another layer. A program already running for fiscal 2026 will now cost about $700 million more than planned, pushing the total to roughly $2.8 billion, tied to layoffs and other reorganization measures. A company pouring billions into new data centers while cutting headcount is reallocating capital toward AI cloud infrastructure and away from legacy operations — a pattern playing out across the technology sector, though Oracle's aggressive backlog growth makes it unusually visible.

Two analysts, two directions

Wall Street's targets have fanned out. UBS raised its price objective to $250 from $245 on Friday, while BMO Capital cut its own to $195 from $220 the same day. The spread captures the open debate: does the order book justify the capital intensity, or will the infrastructure offensive weigh on margins for years?

Management has sought to calm operational nerves. CFO Hilary Maxson and CEO Clay Magouyrk indicated no delays are expected at the New Mexico site relative to the annual forecast.

Brussels in the background

Separately, the European Commission has spent roughly two weeks gathering information on Oracle's software licensing practices following a third-party complaint. The stock has recovered 3.1% since the probe surfaced, suggesting investors do not currently treat it as existential — but it remains a background risk.

The central question for Oracle shareholders is no longer whether the company can grow; the top line and the pipeline answer that. It is whether $664 billion in contracted obligations eventually converts into cash that outpaces the enormous investment required to service it. Until that becomes clearer, the shares are likely to keep mirroring the broader nervousness surrounding AI infrastructure — and Ellison's refusal to sell stands as one counterweight to it.